Sridevi Nagaraja, Jose E Rubio, Junfei Tong, Aravind Sundaramurthy, Anup Pant, Meredith K Owen, Michael A Samaan, Brian Noehren, Jaques Reifman
{"title":"Effects of an active ankle exoskeleton on the walking biomechanics of healthy men.","authors":"Sridevi Nagaraja, Jose E Rubio, Junfei Tong, Aravind Sundaramurthy, Anup Pant, Meredith K Owen, Michael A Samaan, Brian Noehren, Jaques Reifman","doi":"10.3389/fbioe.2025.1533001","DOIUrl":null,"url":null,"abstract":"<p><p>Active lower-body exoskeleton devices can decrease the energy requirement of the human body by providing mechanical assistance to lower-body muscles. However, they also alter gait kinematics and kinetics, and it is not well understood whether such alterations are detrimental or beneficial to the human body. In this pilot study, we investigated the impact of walking with an ankle exoskeleton device on the biomechanics of men while carrying a heavy load. We collected computed tomography images and motion-capture data for five young, healthy men who walked 5 km (∼60 min) with a 22.7-kg load, with and without an active ankle exoskeleton (the ExoBoot EB60). We developed personalized musculoskeletal models and calculated the joint kinematics and kinetics for each participant under each walking condition. Without the ExoBoot, at 5 km compared to 0 km, on average, the peak trunk flexion angle increased by ∼35% and the stride length increased by ∼3.5%. In contrast, with the ExoBoot, the magnitude of the corresponding increases was smaller (∼16% and ∼2%, respectively). After the 5-km walk, compared to walking without the ExoBoot, its use considerably altered hip-related biomechanical parameters, e.g., it increased hip abduction angle by ∼17%, increased hip flexion moment by ∼3.5%, and decreased hip adduction moment by ∼19%. Finally, irrespective of distance, ExoBoot use significantly increased the stance duration and peak ankle plantarflexion angle (<i>p</i> < 0.001). Overall, the use of the ExoBoot induced beneficial alterations in stride length and trunk-, ankle-, and hip-related parameters for men walking with load carriage. The quantitative analysis provided by this pilot study should help guide future investigations and inform the development of standards for safe and effective use of emerging exoskeleton technologies.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1533001"},"PeriodicalIF":4.3000,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11949874/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1533001","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Active lower-body exoskeleton devices can decrease the energy requirement of the human body by providing mechanical assistance to lower-body muscles. However, they also alter gait kinematics and kinetics, and it is not well understood whether such alterations are detrimental or beneficial to the human body. In this pilot study, we investigated the impact of walking with an ankle exoskeleton device on the biomechanics of men while carrying a heavy load. We collected computed tomography images and motion-capture data for five young, healthy men who walked 5 km (∼60 min) with a 22.7-kg load, with and without an active ankle exoskeleton (the ExoBoot EB60). We developed personalized musculoskeletal models and calculated the joint kinematics and kinetics for each participant under each walking condition. Without the ExoBoot, at 5 km compared to 0 km, on average, the peak trunk flexion angle increased by ∼35% and the stride length increased by ∼3.5%. In contrast, with the ExoBoot, the magnitude of the corresponding increases was smaller (∼16% and ∼2%, respectively). After the 5-km walk, compared to walking without the ExoBoot, its use considerably altered hip-related biomechanical parameters, e.g., it increased hip abduction angle by ∼17%, increased hip flexion moment by ∼3.5%, and decreased hip adduction moment by ∼19%. Finally, irrespective of distance, ExoBoot use significantly increased the stance duration and peak ankle plantarflexion angle (p < 0.001). Overall, the use of the ExoBoot induced beneficial alterations in stride length and trunk-, ankle-, and hip-related parameters for men walking with load carriage. The quantitative analysis provided by this pilot study should help guide future investigations and inform the development of standards for safe and effective use of emerging exoskeleton technologies.
期刊介绍:
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.